Transcatheter aortic valve implantation is associated with specific intraprocedural complications such as valve malposition and paravalvular regurgitation that require prompt recognition and management.
This review outlines the prevention, early recognition, and management of specific complications during TAVI to improve procedural outcomes.
Transcatheter aortic valve implantation (TAVI) improves the prognosis of patients with severe aortic stenosis who are deemed too high risk for surgical valve replacement. However, this evolving technology is associated with a wide range of potential complications--some specific to TAVI, some often fatal. Prevention, early recognition, and effective treatment of these complications will significantly improve the outcome of this procedure and are essential prerequisites before the therapy is extended to lower-risk patient subsets.
Laborde et al. (Sun,) conducted a review in Severe aortic stenosis undergoing TAVI. Transcatheter aortic valve implantation (TAVI) was evaluated. Transcatheter aortic valve implantation is associated with specific intraprocedural complications such as valve malposition and paravalvular regurgitation that require prompt recognition and management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: